Ajla Hrle

Company: DISCO Pharmaceuticals GmbH

Job title: Chief Business Officer

Bio:

Ajla is Chief Business Officer at DISCO Pharmaceuticals. From 2023 to 2024, Ajla served as Head of Life Sciences at ATHOS KG, the Strüngmann Family Office. Between 2016 and 2022, she held roles at Immatics N.V., most recently as Vice President of Strategic Alliances. During this time, she completed multiple licensing transactions from early-stage to commercial, contributed to public listings, led fund and direct investments, and established Corporate Communications and Alliance Management departments. Earlier, she led technical sales in Scandinavian markets at NanoTemper Technologies GmbH.

Seminars:

Opportunity to be First-in-Class: Considerations for Collaborations with New Targets 11:10 am

What are the economics of having a new target for others to develop an ADC around? Discussing opportunities to be first-in-class pursuing underexploited targets  Debating the decision to leverage the best linker-payload platform or off-patent technologies, considering the influence on the side effect profileRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.